Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like they tried the old gap the open.
Anyone who has 250+ negative posts loses a lot of credibility.
Yes it's in the consent form
The data was still being gathered and 1st quarter for top line
Fud 101: if no update, outrage. Update, it's all fluff!
How can a person of science predict the outcome of a trial before the trials conclusion? Maybe they aren't really a person of science!
.00925 in the red. Zip code!
Not all statements deserve an answer/comment!
The point is their pps went from a high of $150ish to $3. And that slide to years and years. So it really is a good comparison.
Now with all that being said it's still a post on a anonymous message board.
I agree.. when I read the post it just struck me as being a story that had to much detail for him to make up.
I will say this about the nerby post...it's a very good and detailed story if it's fake.
Yes I know I haven't seen any of your current tests but I am afraid you are going to die! Lol! Can you imagine any real person of science not wanting to see the results! Seriously! You can't make it up.
Again GE for example has a very impressive board and and they meet regularly and the pps is tanking. The meetings haven't helped them and they won't help our share price. What will help is a partnership that hopefully will come from one of the 20+ cdas that have been signed.
GE has a very impressive board and I am sure they meet regularly. Yet their stock is tanking. I only use this example to illustrate that boards don't always have all the answers. In ipix case it's almost all about the science.
There is no institutional shareholders so the negative drum beat has been very effective. Just look at AF's lies.
I can tell you the biofilm issue in the face of an infected total joint is a huge issue and would be a enormous opportunity.
They would! But they took on debt! The debt got called in...end of story!
Science is everything! Otherwise using your logic a privately held company would never be acquired!
People are very tired of arguing about the same thing over and over. It has nothing to do with their belief.
I agree the manipulation bs drives me crazy. Last week they gaped the opening almost every am
Any idea what size?
What's a T trade? Thanks
Also don't forget small biotechs have been out of favor for some time.
Leo has been pushing the science forward since he's been on board. It's your decision as an investor to stay to go or to hold. Maybe you should reevaluate why you are in a small biotech company.
But you are making my point. Small pre revenue biotechs have bad balance sheets because they have no revenues! So if you want a good balance sheet then buy a big pharmaceutical!
The hit pieces now are the daily attacks on multiple boards. This is so out of proportion it's ludicrous. I mean it's a small biotech company with a .66 pps! Why on earth would so many people spend so much time and energy writing hit pieces every day? Why? It makes no logical sense.
The problem AF has is that his personal attacks of management really cloud his thinking of the science. I have seen this to many times. With his ipix attacks it's not clear to me that he has even read the information on the trials or if he is just out right lying.
Management added the additional sites that created the over flow of participates.
Yes. Go and look at the PRs on the company website.
It is a stupid conversation..so stop bring it up. Lol! Smaller early trials are important for guiding and instructing future/larger trials. No company has an unlimited budget and can run large early trials.
And seeing patients is relavent because.....why? His cv is more than impressive and I trust his judgment and instincts when it comes to trials and there potential.
My point was that someone with over 15yrs of experience running trials and analyzing data(never mind a PhD in pharmacology) should be able to interpret data better than some anonymous message board poster.
Thanks for making my point! He is much more qualified to analyse trial data than you.
I believe the real Dr. Knows more about the subject than the naysayers on an anonymous message board. Lol!
Bad example.. Poly had debt! Next
Look under Innovation Pharmaceutical
Do you actually believe anything he says? His statements are obvious lies and easily fact checked.
I am not sure what you were reading this weekend but it was probably the best weekend for scientific and informative posts we have had in a long time!
If they knew the answers(dose response and saftey) before the study then it wouldn't be called a study! They saw a good signal with safety at 200mg. That gave them the info for a bigger trial 2b but of course you know this already.